American Financial Group 401 Retirement & Savings Plan Continues to Hold Holding in American Finl Group Ohio (AFG); As Gilead Sciences (GILD) Stock Declined, Argentiere Capital Ag Lowered by $930,000 Its Position

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

American Financial Group Inc 401 Retirement & Savings Plan increased its stake in American Finl Group Inc Ohio (AFG) by 2.11% based on its latest 2018Q4 regulatory filing with the SEC. American Financial Group Inc 401 Retirement & Savings Plan bought 58,172 shares as the company’s stock declined 5.21% while stock markets rallied. The institutional investor held 2.81M shares of the finance company at the end of 2018Q4, valued at $254.75 million, up from 2.76M at the end of the previous reported quarter. American Financial Group Inc 401 Retirement & Savings Plan who had been investing in American Finl Group Inc Ohio for a number of months, seems to be bullish on the $9.11B market cap company. The stock decreased 0.27% or $0.28 during the last trading session, reaching $101.62. About 69,275 shares traded. American Financial Group, Inc. (NYSE:AFG) has declined 8.54% since May 10, 2018 and is downtrending. It has underperformed by 12.91% the S&P500. Some Historical AFG News: 17/04/2018 - Ken W. Schneider Named Divisional Senior Vice President of Great American Insurance Group; 02/05/2018 - AFG - LAB ENTREPRENØR TO BUILD HARDANGERBADET; 05/04/2018 - American Financial Volume Jumps More Than Six Times Average; 02/05/2018 - American Fincl Group Declares Special Cash Dividend of $1.50/Shr; 30/05/2018 - American Financial at Morgan Stanley Conference Jun 12; 09/04/2018 - Financial 15 Split Corp. Announces Exchange Offering a High Quality Portfolio Consisting of 15 North American Financial Services Companies; 30/05/2018 - American Financial Closes Above 50-Day Moving Average; 02/04/2018 - American Financial Group, Inc. Declares Quarterly Dividend; 25/04/2018 - As Intelligent Customer Care Platforms Experience Rapid Growth, Convergys Introduces Conversational Virtual Assistant Technology to Leading North American Financial Institution; 02/05/2018 - American Fincl Group Backs FY18 Core Net Operating EPS $7.90-$8.40

Argentiere Capital Ag decreased its stake in Gilead Sciences Inc (GILD) by 30% based on its latest 2018Q4 regulatory filing with the SEC. Argentiere Capital Ag sold 15,000 shares as the company’s stock declined 5.41% while stock markets rallied. The hedge fund held 35,000 shares of the health care company at the end of 2018Q4, valued at $2.19 million, down from 50,000 at the end of the previous reported quarter. Argentiere Capital Ag who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $82.00B market cap company. The stock decreased 2.67% or $1.77 during the last trading session, reaching $64.36. About 1.97M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 15.58% since May 10, 2018 and is downtrending. It has underperformed by 19.95% the S&P500. Some Historical GILD News: 18/04/2018 - ASTELLAS PHARMA INC - ASSET TRANSFER WAS COMPLETED ON APRIL 12, 2018; 18/05/2018 - U.S. FDA SAYS ALERTING PUBLIC TO SERIOUS CASES OF NEURAL TUBE BIRTH DEFECTS REPORTED IN BABIES BORN TO WOMEN TREATED WITH DOLUTEGRAVIR USED TO TREAT HIV; 07/05/2018 - AbbVie’s Mavyret Falls After 1-Wk Rise, Epclusa Advances: Hep-C; 09/05/2018 - Harish Manwani Joins Gilead Sciences’ Board of Directors; 18/05/2018 - EU warns of possible birth defect link to GSK’s HIV drug; 15/05/2018 - Gilead fortifies its cell therapy status, expanding into three new facilities and teaming with NCI $GILD; 25/04/2018 - GALAPAGOS NV GLPG.AS - IN 2018, CO’S PARTNER GILEAD TO COMPLETE RECRUITMENT OF REMAINING RA PHASE 3 STUDIES WITH FILGOTINIB; 06/03/2018 - Searching for HIV cure, Gilead’s new ‘shock and kill’ combo swats back lethal virus in monkeys $GILD; 30/04/2018 - Gilead’s Descovy Falls For 2nd Wk, Odefsey Declines: HIV; 09/05/2018 - Harish Manwani Joins Gilead Sciences’ Board of Directors

Argentiere Capital Ag, which manages about $464.87 million and $320.32M US Long portfolio, upped its stake in Weibo Corp (NASDAQ:WB) by 8,025 shares to 50,008 shares, valued at $2.92 million in 2018Q4, according to the filing. It also increased its holding in United States Stl Corp New (NYSE:X) by 18,095 shares in the quarter, for a total of 142,395 shares, and has risen its stake in Transocean Ltd (NYSE:RIG).

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on July, 24. They expect $1.53 earnings per share, down 12.57% or $0.22 from last year’s $1.75 per share. GILD’s profit will be $1.95B for 10.52 P/E if the $1.53 EPS becomes a reality. After $1.67 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -8.38% negative EPS growth.

Since November 29, 2018, it had 0 insider purchases, and 1 insider sale for $3.56 million activity.

Investors sentiment decreased to 0.6 in 2018 Q4. Its down 0.29, from 0.89 in 2018Q3. It dropped, as 95 investors sold GILD shares while 543 reduced holdings. 95 funds opened positions while 286 raised stakes. 995.36 million shares or 3.36% more from 963.01 million shares in 2018Q3 were reported. Mark Sheptoff Fincl Planning Ltd reported 217 shares. Moreover, D E Shaw & Communication Incorporated has 0.21% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 2.39 million shares. Blair William Company Il has invested 0.59% in Gilead Sciences, Inc. (NASDAQ:GILD). Brookmont Capital Mngmt has invested 1.63% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 41,236 are held by Comerica Secs Incorporated. 54,273 were accumulated by Optimum Investment Advisors. Tiaa Cref Inv Mngmt Ltd Liability Corp has invested 0.49% in Gilead Sciences, Inc. (NASDAQ:GILD). Sterneck Cap Mgmt Lc holds 2.31% or 37,939 shares. Strategic Advsr accumulated 7,518 shares. Int Sarl, a California-based fund reported 13,500 shares. 9,000 were accumulated by Horizon Kinetics. Moreover, Advsrs Preferred Ltd Liability has 0.04% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 484 shares. Moreover, Quadrant Capital Management Limited Liability Co has 0.77% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 18,741 shares. Shoker Invest Counsel holds 0.27% in Gilead Sciences, Inc. (NASDAQ:GILD) or 5,134 shares. Leuthold Grp stated it has 0.39% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD).

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Fool.com which released: “Where Will Gilead Sciences Spend Its Cash? - Motley Fool” on May 07, 2019, also Nasdaq.com with their article: “GILD vs. ALKS: Which Stock Is the Better Value Option? - Nasdaq” published on April 25, 2019, Fool.com published: “2 Reasons Gilead Sciences’ NASH Program Could Bounce Back - The Motley Fool” on April 27, 2019. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: “Amicus’ (FOLD) Earnings & Revenues Miss Estimates in Q1 - Nasdaq” published on May 09, 2019 as well as Nasdaq.com‘s news article titled: “Notable ETF Inflow Detected - IBB, CELG, GILD, BIIB - Nasdaq” with publication date: April 25, 2019.

Investors sentiment increased to 1.05 in 2018 Q4. Its up 0.10, from 0.95 in 2018Q3. It increased, as 24 investors sold AFG shares while 112 reduced holdings. 54 funds opened positions while 89 raised stakes. 56.50 million shares or 6.38% more from 53.11 million shares in 2018Q3 were reported. Putnam Investments Limited Liability Company has 45,754 shares. Oregon Pub Employees Retirement Fund holds 0.02% of its portfolio in American Financial Group, Inc. (NYSE:AFG) for 2.46M shares. Covington Inv Advsrs reported 43,227 shares or 1.49% of all its holdings. Swiss Bank & Trust owns 0.03% invested in American Financial Group, Inc. (NYSE:AFG) for 246,000 shares. Cramer Rosenthal Mcglynn has 0.34% invested in American Financial Group, Inc. (NYSE:AFG). 100 are held by Oakworth Capital. 18,185 are owned by Investec Asset Mgmt North America Inc. Jpmorgan Chase Commerce holds 0% in American Financial Group, Inc. (NYSE:AFG) or 210,583 shares. Huntington Fincl Bank has invested 0% in American Financial Group, Inc. (NYSE:AFG). Enterprise Fincl Serv Corporation reported 255 shares or 0.01% of all its holdings. Tci Wealth Advisors Incorporated holds 35 shares or 0% of its portfolio. Tower (Trc) accumulated 3,672 shares. Pennsylvania, a Pennsylvania-based fund reported 3,300 shares. 27 are owned by Destination Wealth. Smithfield reported 70 shares or 0% of all its holdings.

Since December 12, 2018, it had 1 buy, and 2 selling transactions for $10.04 million activity. 1,359 shares were sold by VON LEHMAN JOHN I, worth $131,204 on Monday, February 11. On Tuesday, December 18 the insider LINDNER CARL H III sold $10.00M.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.